Sponsor Deadline
Posted: 4/18/2022

FDA -- Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed

CBER seeks to support several research projects that are focused on developing novel technologies for the advanced manufacturing of complex biologic products or innovative analytical approaches for improving product manufacturing and quality.

  Deadlines:
  • Letter of Intent Due Date(s): April 1, 2021

  • Application Due Date(s): May 18, 2021

RFA-FD-21-033 Expiration Date May 19, 2021

Amount Description

Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):

YR 01: $500,000

YR 02: $500,000

YR 03: $500,000

Funding Type
Eligibility
Posted
4/18/2022
Deadline
Sponsor: